Concepedia

Alison Hirukawa

AH

Statistics

Publications

6

Citations

222

H-Index

6

Active since

2018

Affiliations

McGill University(Current)

McGill University Health Centre

National Cancer Institute

Michigan State University

Alison Hirukawa is an author at McGill University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2018–2023

6

Publications

6

Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program

Alison Hirukawa, Harvey W. Smith, Dongmei Zuo et al. · Nature Communications · 2018 · 84 citations · Full text

, , +17

An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis

Harvey W. Smith, Alison Hirukawa, Virginie Sanguin‐Gendreau et al. · Nature Communications · 2019 · 41 citations · Full text

, , +17

Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy

Alison Hirukawa, Salendra Singh, Jarey H. Wang et al. · Cell Reports · 2019 · 40 citations · Full text

, , +17

Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways

L Liu, Bin Xiao, Alison Hirukawa et al. · Proceedings of the National Academy of Sciences · 2023 · 25 citations · Full text

, , +17

A Tri‐Droplet Liquid Structure for Highly Efficient Intracellular Delivery in Primary Mammalian Cells Using Digital Microfluidics

Samuel R. Little, Ziuwin Leung, Angela B. V. Quach et al. · Advanced Materials Technologies · 2023 · 17 citations · Full text

, , +17

1–5 of 6